AlphaCrest Capital Management LLC - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 111 filers reported holding FIBROGEN INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
AlphaCrest Capital Management LLC ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2022$777,000
+6.1%
59,748
-13.8%
0.05%
+34.3%
Q2 2022$732,000
+191.6%
69,338
+232.6%
0.04%
+150.0%
Q1 2022$251,000
-8.4%
20,847
+102.4%
0.01%
+16.7%
Q2 2021$274,000
-51.0%
10,300
-24.3%
0.01%
-80.3%
Q3 2020$559,000
+57.5%
13,600
+41.7%
0.06%
+177.3%
Q3 2019$355,000
+25.4%
9,600
+84.6%
0.02%
-48.8%
Q1 2019$283,0005,2000.04%
Other shareholders
FIBROGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 605,713$9,703,5225.73%
ARMISTICE CAPITAL, LLC 3,864,000$61,901,2801.08%
Logos Global Management LP 525,000$8,410,5000.98%
5AM Venture Management, LLC 225,583$3,613,8400.97%
Intercontinental Wealth Advisors, LLC 191,300$3,064,6260.91%
BHK Investment Advisors, LLC 87,550$1,402,5510.79%
Integral Health Asset Management, LLC 175,000$2,803,5000.59%
Nan Fung Group Holdings Ltd 34,106$546,3780.38%
Soleus Capital Management, L.P. 113,463$1,817,6770.26%
Point72 Asset Management, L.P. 4,781,645$76,601,9530.26%
View complete list of FIBROGEN INC shareholders